These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 16438129)
1. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Tangpukdee N; Krudsood S; Thanachartwet W; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Wilairatana P; Phongtananant S; Kano S; Looareesuwan S Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1085-91. PubMed ID: 16438129 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. Tangpukdee N; Krudsood S; Thanachartwet V; Pengruksa C; Phophak N; Kano S; Li G; Brittenham GM; Looareesuwan S; Wilairatana P Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):1-8. PubMed ID: 18567436 [TBL] [Abstract][Full Text] [Related]
4. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand. Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545 [TBL] [Abstract][Full Text] [Related]
5. An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. Wilairatana P; Krudsood S; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Treeprasertsuk S; Looareesuwan S Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):519-24. PubMed ID: 12693586 [TBL] [Abstract][Full Text] [Related]
6. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533 [TBL] [Abstract][Full Text] [Related]
7. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422 [TBL] [Abstract][Full Text] [Related]
8. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos). Mayxay M; Thongpraseuth V; Khanthavong M; LindegÄrdh N; Barends M; Keola S; Pongvongsa T; Phompida S; Phetsouvanh R; Stepniewska K; White NJ; Newton PN Trop Med Int Health; 2006 Aug; 11(8):1157-65. PubMed ID: 16903879 [TBL] [Abstract][Full Text] [Related]
9. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. Valecha N; Phyo AP; Mayxay M; Newton PN; Krudsood S; Keomany S; Khanthavong M; Pongvongsa T; Ruangveerayuth R; Uthaisil C; Ubben D; Duparc S; Bacchieri A; Corsi M; Rao BH; Bhattacharya PC; Dubhashi N; Ghosh SK; Dev V; Kumar A; Pukrittayakamee S PLoS One; 2010 Jul; 5(7):e11880. PubMed ID: 20689583 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India. Gargano N; Ubben D; Tommasini S; Bacchieri A; Corsi M; Bhattacharyya PC; Rao BH; Dubashi N; Dev V; Ghosh SK; Kumar A; Srivastava B; Valecha N Malar J; 2012 Jul; 11():233. PubMed ID: 22818552 [TBL] [Abstract][Full Text] [Related]
12. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Looareesuwan S; Viravan C; Vanijanonta S; Wilairatana P; Suntharasamai P; Charoenlarp P; Arnold K; Kyle D; Canfield C; Webster K Lancet; 1992 Apr; 339(8797):821-4. PubMed ID: 1347854 [TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. Grande T; Bernasconi A; Erhart A; Gamboa D; Casapia M; Delgado C; Torres K; Fanello C; Llanos-Cuentas A; D'Alessandro U PLoS One; 2007 Oct; 2(10):e1101. PubMed ID: 17971864 [TBL] [Abstract][Full Text] [Related]
14. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Karbwang J; Bangchang KN; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T Lancet; 1992 Nov; 340(8830):1245-8. PubMed ID: 1359318 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Karema C; Fanello CI; van Overmeir C; van Geertruyden JP; van Doren W; Ngamije D; D'Alessandro U Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1105-11. PubMed ID: 16766006 [TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Ashley EA; McGready R; Hutagalung R; Phaiphun L; Slight T; Proux S; Thwai KL; Barends M; Looareesuwan S; White NJ; Nosten F Clin Infect Dis; 2005 Aug; 41(4):425-32. PubMed ID: 16028147 [TBL] [Abstract][Full Text] [Related]
17. A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos. Mayxay M; Keomany S; Khanthavong M; Souvannasing P; Stepniewska K; Khomthilath T; Keola S; Pongvongsa T; Phompida S; Ubben D; Valecha N; White NJ; Newton PN Am J Trop Med Hyg; 2010 Dec; 83(6):1221-9. PubMed ID: 21118925 [TBL] [Abstract][Full Text] [Related]
18. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185 [TBL] [Abstract][Full Text] [Related]
19. A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen. Wilairatana P; Krudsood S; Chokejindachai W; Bussaratid V; Silachamroon U; Viriyavejakul P; Hendriksen C; Scheiwe MW; Looareesuwan S Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):696-701. PubMed ID: 10772548 [TBL] [Abstract][Full Text] [Related]
20. Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children. Gomez EA; Jurado MH; Cambon N Acta Trop; 2003 Dec; 89(1):47-53. PubMed ID: 14636982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]